Friday, April 14, 2017 3:51:36 PM
leaving a minimal amount of 'macro cells' under 1mm likely and and microcells that are hypothesised to be the cause of recurrence.
I see no reason a 1/2 dose can't do the job seeing as the scrapping took care of the 'heavy work' so to speak..i.e. depth of tumour etc.
The question is
Does the Green light work best?
Does the DFOC homogeniously distribute the light dosage properly and eliminate 'hot spots' and if u watch dr.Lilge talk about lasers... overdosing the light to tissue causes problems.. my hunch is that in 1998 with no dosimitry (way to control the distribution and having a limited motitoring light system, led to the safety failure just as much as the Photofrin drug itself.
The value of the entire system cannot be understated... and when validated in 2 weeks.. we're de-risked..... open the flood gates
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM